1,25(OH) 2 D 3 Treg/Th17 cells VDR /PLC-γ1/TGF-β1 pathway A B S T R A C T Vitamin D has been recommended as an immune modulator in recent years, in addition to regulating calcium-phosphorous-bone metabolism. Clinical studies on organ transplantation found that vitamin D sufficiency patients were less likely to develop acute cellular rejection within one year after transplantation compared to those with vitamin D deficiency. Thus, a high percentage of regulatory T cells might play a key role in preventing acute cellular rejection (ACR). In this report, we studied the specific effects of 1,25(OH) 2D3 on human T cell diff ;erentiation, and determined the potential molecule mechanism behind. Results showed that 1,25(OH)2D3 induced the differentiation of T-regulatory cells (Treg cells), while inhibiting Th17 cell proliferation. In addition, 1,25(OH)2D3 promoted secretion of the anti-inflammatory cytokine, transforming Growth Factor beta1 (TGF-β1) but suppressed pro-inflammatory cytokines such as interleukin-17 (IL-17). Phospholipase C gamma 1 (PLC-γ1) is an indispensable signaling protein downstream of the classical TCR signaling pathway and was shown to play a crucial role in T cell activation, while Naive T cells expressed less PLC-γ1. Here we showed that Vitamin D could significantly upregulate PLC-γ1 expression, which then induced expression of TGF-β1. In summary, 1,25(OH)2D3 indirectly modulates the differentiation of Treg/Th17 cells by aff ;ecting the VDR/PLC-γ1/TGF-β1pathway. These results indicate that administration 1,25(OH)2D3 supplements may be a beneficial treatment for organ transplantation recipients.
Introduction
], the active form of vitamin D, plays a key role in maintaining calcium and phosphorus homeostasis. However, increasing reports indicate that vitamin D also has important immunomodulatory properties (Chun et al., 2014; Wei and Christakos, 2015) . In the adaptive immune system, vitamin D acts as an immune suppressor. Epidemiological studies have found that autoimmune diseases including Type 1 diabetes, multiple sclerosis, and systemic lupus erythematosus (SLE) are related to vitamin D deficiency (Gianfrancesco et al., 2017; Prietl et al., 2013) . In addition, daily vitamin D supplementation could reduce the risk of type 1 diabetes and multiple sclerosis (Hypponen et al., 2001; Salzer et al., 2012) . In the innate immune system, for instance, vitamin D could induce human monocyte-derived dendritic cells (DCs) to express a tolerogenic phenotype in vitro. 1,25(OH) 2 D 3 -modulated tolerogenic DCs express low mature surface molecules including HLA-DR and costimulatory molecules (CD80, CD86), instead of secreting additional IL-10 (Ferreira et al., 2015) . 1,25(OH) 2 D 3 acts on the vitamin D receptor (VDR), which belongs to the nuclear hormone receptor superfamily (Coussens et al., 2012) . When interacting with 1,25(OH) 2 D 3 , VDR heterodimerizes with retinoid X receptor (RXR) and binds target DNA sequences called vitamin D response elements (VDRE) to regulate the expression of interrelated downstream target genes.
PhospholipaseC-γ1 (PLC-γ1) is an important signaling protein participating in the classical TCR signaling pathway. PLC-γ1 plays a crucial role in T cells activation while Naive T cells express less PLC-γ1 (Bradl et al., 2014) . The substrate of phosphorylated PLC-γ1 is phosphatidylinositol-4,5-bisphosphate (PIP2), hydrolyzed to inositol-1,4,5-trisphosph-e (IP 3 ) and diacylglycerol (DAG). IP 3 and DAG then act as second messengers regulating intracellular calcium mobilization. Thus, the increased Ca + concentration and Ca + signaling pathway induces several important transcription factors which trigger the expression of several genes involved in T-cell activation and cell-cycle entry (von Essen et al., 2010) . Another important element related to 1,25(OH) 2 D 3 in our research is transforming growth factor beta 1 (TGF-β1) produced by many types of cells. TGF-β1 is a kind of immunosuppressive cytokine that plays a pleotropic role in regulating a variety of immune cells (Rubtsov and Rudensky, 2007 (Maywald et al., 2017) by inducing gene encoding forkhead box P3 (FOXP3) (Dardalhon et al., 2008; Marie et al., 2005) . FOXP3 is the specific transcription factor found in Treg cells (Ren and Li, 2017) . Treg cells were first detected and identified as a master regulator of maintaining immune homeostasis in patients with autoimmune disease. Individuals who suffer from X-linked syndrome (IPEX) have an inadequate numbers of Treg cells (Bacchetta et al., 2016 ) and a mutated FOXP3, which could be alleviated or treated successfully by the adoptive transfer of Treg cells in mouse models (Tang et al., 2004) . Furthermore, additional studies showed that defects in Treg cells function contributes to the development of Type 1 diabetes, rheumatoid arthritis, and IBD, which could be prevented or cured potentially by therapies directed at these defects. Treg cells mediate immune suppression through many mechanisms including secreting inhibitory cytokines (IL-10, TGF-β1), direct contact with effector T cells to disrupt metabolism, and targeting dendritic cells (Vignali et al., 2008) . Th17 cells, which are characterized by the secretion of IL-17, IL-21/22, and expression of the specific transcription factor, the retinoidrelated orphan receptor (RORγt), are instrumental in promoting auto-inflammatory diseases such as multiple sclerosis (MS), rheumatoid arthritis (RA), and inflammatory bowel diseases (IBDs) (Noack and Miossec, 2014; Waite and Skokos, 2012) . For example, elevated levels of IL-17 (Montes et al., 2009; Tzartos et al., 2008) have been found in cerebrospinal fluid (CSF) and serum from MS patients. Further evidence showed that increased levels of IL-17A in the peripheral blood were produced and detected as well as increased numbers of Th17 cells (Eastaff-Leung et al., 2010) and anti-CD28 (clone CD28.2, BD Biosciences_555725) monoclonal antibodies, at a concentration of 5 μg/ mL of each antibody, for 3 days, and the cells were re-stimulated with PMA (50 ng/mL) and ionomycin (500 ng/mL) for another 3 days (5% CO 2 at 37°C). CD3 clone UCHT1 is optimal for the immobilized format according to manufacturer's instructions, so the CD3 UCHT1 antibodies were coated onto a plate at 5 μg/mL at 4°C overnight before stimulation.
Lentiviral vector construction and establishment of PLC-γ1 overexpression cells
Full-length cDNA encoding PLC-γ1 was ampifed by PCR with primer (F: 5′-AGGTCGACTCTAGAGGATCCCGCCACCATGGCGGGCGCCGCGTCC CCTTGCGCCAACG, R:5′-TCCTTGTAGTCCATACCGAGGCGGTTGTCTCCA TTGACCCG AGTCC-3′). Subsequently, the purified PLC-γ1 PCR products were ligated to GV492 vector (GV492-PLC-γ1) (Genechem Co., Ltd, shanghai, China) according to the manufacturer's instructions. The GV492-PLC-γ1 expression construct or the empty GV492 vector was transfected into the 293FT cell line. Virus-containing supernatants were collected for subsequent transduction into Jurkat cell line. Cells were infected with the viruses at a multiplicity of infection (MOI) of 20. At 3 days after virus transduction, the transfected cells were cultured for 1 days with 5 μg/mL puromycin (OriGene) for the establishment of stable cells.
Western blots
Cells were lysed in an ice-cold lysis buffer (150 mM NaCl, 0.02% NaN3, 0.1% SDS, 50 mM TrisCl, pH 8.0, 100 μg/mL phenylmethylsulfonyl fluoride, 1 μg/mL aprotinin, and 1% Triton). Samples of lysate containing 25 μg of protein were separated on a 10% SDS-PAGE gel, and the protein bands were transferred onto PVDF membranes (Millipore; Billerica, MA, USA). The PVDF membranes were then blocked with TBST buffer containing 5% skim milk for 1 h. After washing with TBST buffer thrice for 15 min each, they were incubated with primary antibodies specific for PLC-γ1 (1:1000, Cell Signaling Technology_2822), TGF-β1 (1:1000, Cell Signaling Technology_3709), VDR (1:500, abcam_3508), P-PLC-γ1 (1:1000, Cell Signaling Technology_2821), TGF-β1 (1:1000, Cell Signaling Technology_3709), IL-17A (1:1000, R & D Systems_MAP3171), RORγt (1:1000, R & D Systems_562197), and Foxp3 (1:1000, absin_118887), GAPDH (1：2000, BBI Life Science_D110016). After washing with TBST buffer thrice for 15 min each, the gels were then counterstained with HRPconjugated goat anti-rabbit secondary antibodies (Promab Biotechnologies, 1:1000; Richmond, CA, USA), The individual protein bands were detected with the enhanced chemiluminescence (ECL) reaction (Kibbutz Beit Haemek, Israel), and the staining intensity of each band was quantified using Quantity One software (BioRad Laboratories; Hercules, CA, USA).
Enzyme-linked immunosorbent assay (ELISA) for cytokines
The concentrations TGF-β1 in culture supernatants were measured by ELISA kits (R & D Systems_DB100B), according to the manufacturer's instructions. The limits of detection were 6.25 pg/mL for TGF-β1.
Real-time polymerase chain reaction (PCR)
Total cellular RNAs were isolated using TRIzol reagent according to the manufacturer's instructions. cDNA was synthesized from the purified RNA using a reverse-transcription system (Roche, Germany). Realtime PCR was performed on the Applied Biosystems™ ViiA™ 7 system (Thermo Fisher, USA) by using SYBR Green (Roche, Germany, Cat No: 4913914001) as a double-stranded DNA-specific binding dye. GAPDH was used to normalize the gene expression levels. The PCR primer sequences are listed in Table 1 . The PCR reactions were operated for 40 Table 1 Primer sequences for real-time polymerase chain reaction.
Gene
Forward sequence (5′ → 3′) Reverse sequence (5′ → 3′) Molecular Immunology 91 (2017) 156-164 cycles after initial denaturation (95°C, 5 min) with the following parameters: denaturation at 95°C for 15 s, annealing at 60°C for 15 s, extension at 72°C for 35 s. Following the analyses, fold differences in results between groups were determined using the comparative cycle threshold (CT) method. Fold-changes were calculated from the ΔΔCT values, and using the formula 2 −ΔΔCT .
Flow cytometry
After 3 days of stimulation by anti-CD3/CD28, the cells were restimulated with PMA (50 ng/mL) and ionomycin (500 ng/mL) in the presence of 1,25(OH) 2 D 3 for 72 h. Cells were separated, washed, resuspended, and stained with various antibody mixtures using the methods described in the manufacturer's instructions, including CD4 (BD_560167), CD25 (BD550795), CD127 (BD_564423), FOXP3 (BD_560852), IL-17A (BD_560486), and RORγt (BD_563081). When detecting Th17 cells, the cells were first incubated for 6 h with phorbol myristate acetate (50 ng/mL) and ionomycin (750 ng/mL) in the presence of monensin at 37°C. All human monoclonal antibodies were purchased from Becton Dickinson (BD PMG, USA)
Statistical analysis
All results are presented as the mean ± S.E.M of data obtained from at least three independent experiments. The T-test was used to analyze parametric data and the Mann-Whitney U test was used to analyze non-parametric data. P-values < 0.05 were considered statistically significant. RORγt. GAPDH was used as a loading control. Data are representative of three separate experiments or more experiments and represent the mean ± SEM. * P < 0.05, **P < 0.01, *** P < 0.001.
Results

1,25(OH) 2 D 3 induces Treg cell differentiation and expression of TGF-β1 and FOXP3
To analyze the comprehensive and specific effects of 1,25(OH) 2 D 3 on human T cells, human Jurkat clone E6-1T cells were used as a model in this study. Jurkat clone E6-1T cells were stimulated with anti-CD3/ anti-28 Abs (Nguyen et al., 2016) for 3 days and cells were re-stimulated with PMA (50 ng/mL) and ionomycin (500 ng/mL) in the presence or absence of 1,25(OH) 2 D 3 (10 nM). As reported in recent studies, CD127 (a chain of the IL-7 receptor) expression inversely correlated with FOXP3, and low CD127 cell surface expression within CD4 CD25 expression was recommended as an important and specific marker of Treg cells compared to other cell surface markers (Liu et al., 2006; Seddiki et al., 2006) . Therefore, the expression of CD127 was also detected by flow cytometry. The present study revealed that the percentage of CD4 + CD25 + CD127 −/lo Treg cells was significantly increased (Fig. 1A, C) . Furthermore, FOXP3+ Treg cells differentiation, expression of FOXP3, and the level of cytokines TGF-β1 in the supernatants were examined. The results showed that the CD4 + CD25 + FOXP3 + Treg cell differentiation increased significantly (Fig. 1B, D) in the presence of 1,25(OH) 2 D 3 . As illustrated in Figs. 1E and F, the secretion of TGF-β1 increased significantly in the presence of 1,25(OH) 2 D 3 . In addition, 1,25(OH) 2 D 3 had upregulated the expression of both FOXP3 mRNA and protein during T cell differentiation (Fig. 1E, G) . and TGF-β1. Data are representative of three separate experiments or more experiments and represent the mean ± SEM. * P < 0.05, **P < 0.01, *** P < 0.001.
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1,25(OH)2D3 inhibits Th17 cell differentiation and the expression of RORγt and IL-17A
Based on previous studies, the function of Treg cells and Th17 cells were shown to be mutually inhibited. Therefore, it was hypothesized that 1,25(OH) 2 D 3 induced Treg cells, while suppressing the differentiation of Th17 cells. As illustrated in Fig. 2A and C, 1,25(OH) 2 D 3 inhibited Th17 cell differentiation. RORγt is the specific transcription factors expressed in Th17 cells. Thus, the studies presented here showed that 1,25(OH) 2 D 3 inhibited the expression of RORγt (Fig. 2B, D, E) . Additionally, the secretion of the pro-inflammatory cytokine IL-17A was decreased (Fig. 3F). 3.3. Effects of 1,25(OH) 2 D 3 on the expression of PLC-γ1 and TGF-β1
As previous studies have shown, activated T cells induced upregulation of PLC-γ1 expression, while Naive T cells express less PLC-γ1 (Nguyen et al., 2016) (Fig. 3A) . The active state of PLC-γ1 is the phosphorylation of PLC-γ1 (P-PLC-γ1). Expression of VDR, P-PLC-γ1, and TGF-β1 were measured in the activated T cells stimulated with 1,25(OH) 2 D 3 at times ranging from 3 h to as long as 24 h. The result of western blotting indicated that the expression of PLC-γ1, P-PLC-γ1, and TGF-β1 significantly increased at the same time point of 12 h in the presence of 1,25(OH) 2 D 3 (Fig. 3B, C) . The same result was detected on the mRNA expression of PLC-γ1 and TGF-β1 (Fig. 3D) . Hence, we hypothesized that PLC-γ1 was involved in inducing the expression of TGF-β1.
VDR/PLC-γ1/TGF-β1 pathway participated in modulating the Treg cell differentiation induced by 1,25(OH) 2 D 3 in vitro
To determine whether PLC-γ1 was involved in inducing the expression of TGF-β1 and whether 1,25(OH) 2 D 3 induced regulatory T cells by regulating the VDR/PLC-γ1/TGF-β1 pathway, activated wildtype E6-1 Jurkat and PLC-γ1-deficient Jurkat gamma1 cells were stimulated in the presence or absence of 1,25(OH) 2 D 3 for 24 h. The Jurkat gamm1 cell line is a PLC-γ1 deficient mutant of the E6-1 clone of Jurkat cells, which expressed no detectable PLC-γ1 protein (Nguyen et al., 2016) . The lack of PLC-γ1 expression in Jurkat gamm1 cells caused profound defects in the T cell receptor (TCR), calcium mobilization, and nuclear factors of activated T-cell (NFAT) activation. Jurkat gamma1 cells expressed less TGF-β1 protein than in Jurkat clone E6-1 cells (Fig. 4A) . Next, Jurkat E6-1 and Jurkat gamma1 cells were transfected with GV492-PLC-γ1 expression constructs by virus vectors. An empty vector plasmid was used as a control (Fig. 4B) . As a result, the expression of TGF-β1 was detected in the Jurkat cell line. It was found both protein and mRNA expression of TGF-β1 were significantly increased both in Jurkat E6-1 and Jurkat gamma1 transfected with GV492-PLC-γ1 over the control group (Fig. 4C, D, E, F) . This result was found as well as in the presence of 1,25(OH) 2 D 3 (Fig. 4C ).
Discussion
Recent studies have shown that vitamin D has important clinical significance in organ transplantation. John R. Lee and colleagues performed a study of 351 kidney graft recipients measuring circulating levels 25(OH)D 3 after transplantation. 25(OH)D 3 is the inactive precursor of 1,25(OH) 2 D 3 . They found that 61.5% of the patients were vitamin D deficient (circulating levels 25(OH)D 3 less than 20 ng/mL). In addition, vitamin D deficient patients were more likely to develop acute cellular rejection(ACR) within one year after transplantation compared to those with vitamin D sufficiency (P = 0.02). Herein, vitamin D deficiency increases the incidence of ACR. Conversely, vitamin D supplementation could reduce the occurrence of ACR significantly (Lee et al., 2014) . The inhibitory effect of vitamin D levels on ACR has been proven in recipients of organs in addition to kidney grafts. A study by Davide Bitetto of 133 liver transplant recipients by Davide Bitetto demonstrated that the low pre-transplant circulating levels (< 5 ng/ mL) of 1,25(OH) 2 D 3 were at risk for moderate-to-severe ACR episodes within two months after transplantation. Additionally, a daily supplementation of 800 UI may relieve the severity of ACR (Bitetto et al., 2010) . Therefore, we hypothesized that 1,25(OH) 2 D 3 induced Treg cells, while suppressing the differentiation of Th17 cells to modulate ACR.
Recently, the action of Treg cells and Th17 cells in transplantation has become of great interest (Crispim et al., 2009 ), more than simply the clinical significance in autoimmune disease. In a study of renal allografts by Byung H. Chung et al., Th17 cell infiltration and levels of IL-17 were demonstrated to be closely associated with the progression of allograft dysfunction or tissue injury in acute T cell-mediated rejection (ATCMR) (Chung et al., 2011) , as well as clinical chronic rejection (Deteix et al., 2010) . One possibility could be that IL-17 could recruit neutrophils, thus hastening more severe rejection (Healy et al., 2006) . This pathology was detected in biopsies. In addition, less allograft dysfunction and tissue injury was observed in the FOXP3 high group compared with the IL-17 high group. The high percentage of FOXP3+ Treg cells significantly increased the long-term allograft survival rate at 1 year. The function of CD4 + CD25 + FOXP3 + T cells in transplantation was researched further in clinic trials. In a clinic trial of acute graftversus-host disease (aGVHD) post haplo-identical hematopoietic stem cell transplantations (haplo-HSCT) performed by Li Ding and his colleagues, showed that a high percentage of Treg cells in peripheral blood (PB) grafts could significantly reduce the occurrence of aGVHD in haplo-HSCT. In this study, it was shown that 1,25(OH) 2 D 3 could affect the human adaptive immune response by increasing the percentage of Treg cells, while inhibiting Th17 proliferation. In addition, the main pathway, through which Treg cells mediate immune suppression and inhibit ACR, is by secreting inhibitory cytokines (IL-10, TGF-β1). The studies presented here also found that 1,25(OH) 2 D 3 increased the expression of TGF-β1. TGF-β1 is a cytokine that acts as an immune suppressor by regulating immune cells differentiation, tolerance induction, while also preventing autoimmune diseases (Ahn et al., 2011) . TGF-β1 was shown to induce Treg cell differentiation by inducing FOXP3 expression (Dardalhon et al., 2008) , while Th17 proliferation increased in the absence of TGF-β1 (Ghoreschi et al., 2010 PLC-γ1 is an important signaling protein downstream of the classical TCR signaling pathway and. PLC-γ1 plays a crucial role in T cell activation while Naive T cells express less PLC-γ1. Previous studies showed that the gene encoding PLC-γ1 depends on 1,25(OH) 2 D 3 -VDR signaling (von Essen et al., 2010) . However, the results presented here were inconsistent. These data showed that TCR triggering activated the expression of PLC-γ1, which is involved in T cell activation and differentiation. Vitamin D, or any active products, were not detectable in cell culture fluid. However, the similarity was that 1,25(OH) 2 D 3 upregulated the expression of PLC-γ1. Furthermore, it was found that expression of PLC-γ1, P-PLC-γ1, and TGF-β1 significantly increased at the same time point of 12 h in the presence of 1,25(OH) 2 D 3 . Then, to determine whether PLC-γ1 was involved in promoting TGF-β1 gene coding, Jurkat.gamma1 was used as a control model. The Jurkat gamm1 cell line is a phospholipase C-gamma1 (PLC-γ1) deficient mutant of the E6-1 clone of Jurkat cells. The lack of PLC-γ1 expression in Jurkat gamma1 cells caused profound defects in the T cell receptor (TCR), calcium mobilization, and nuclear factors of activated T-cell (NFAT) activation. Jurkat gamma1 cells expressed less TGF-β1 protein than in the Jurkat clone E6-1. Upregulated expression of PLC-γ1 in Jurkat E6-1 and Jurkat gamma1 cells by transfection with GV492-PLC-γ1 was performed. Results indicated that both protein and mRNA Data are representative of three separate experiments or more experiments and represent the mean ± SEM. * P < 0.05, **P < 0.01, *** P < 0.001. Q. Zhou et al. Molecular Immunology 91 (2017) 156-164 expression of TGF-β1 were significantly increased in both Jurkat E6-1 and Jurkat gamma1 cells. Therefore, it was confirmed that PLC-γ1 played a key role in inducing the expression of TGF-β1. In summary, the data presented here indicate that 1,25(OH) 2 D 3 induces regulatory T cell differentiation by regulating the VDR/PLC-γ1/TGF-β1 pathway. One plausible limitation in the studies presented above is that human primary T cells were not used to further identify the effects of 1,25(OH) 2 D 3 on human T cell differentiation, and the pathway discovered in the Jurkat cell line. However, as previous studies have reported, Jurkat E6-1 cells could constitutively express PLC-γ1. (Irvin et al., 2000) Furthermore, the PLC-γ1 deficient phenotype of Jurkat gamma1 cells is an advantage in the present study in that we were able to focus on PLC-γ1 signaling functions in Treg cell differentiation. The Jurkat cell line is typically used as a cell model for research on TCR signaling (Abraham and Weiss, 2004; Larghi et al., 2013; Sherman et al., 2011) , PLC-γ1 (Bivona et al., 2003; Ericsson et al., 1996; Rouquette-Jazdanian et al., 2012) , and other signaling pathways associated with cell differentiation (Apostolidis et al., 2016; Su et al., 2016) in human T cells. Therefore, it was determined that Jurkat T cells are functionally comparable to primary T cells and can be used to study the molecular mechanism of VDR-PLC-γ1-signaling pathways.
The aim of the present study on 1,25(OH) 2 D 3 on human CD4 + T cells was to elucidate the molecular mechanism involved in the observed 1,25(OH) 2 D 3 increase in Treg cell differentiation preventing the occurrence of acute cellar rejection after liver transplantation. Results from the present study on 1,25(OH) 2 D 3 -induced Treg cells differentiation can be used for new therapeutic targets, and drug research to help patients with liver transplantation to prevent ACR, apart from CNIbased immunosuppressive regimens. Vitamin D is a common and inexpensive drug used in the treatment of osteoporosis and now can be used in patients with liver transplantation. This research supports the use of Vitamin D supplements as a therapy used for liver transplantation patients.
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